RARRES2 and cancer: Research focused on biomarkers such as chemerin, which is implicated in both metabolic regulation and inflammation, could provide critical insights into the pathophysiology of upper GI cancers and offer new opportunities for targeted therapies, potentially improving outcomes for cancer patients.